Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure ...

Debiopharm initially received funding from CARB-X in 2017 for pre-clinical development of Debio1453, which inhibits an ...

With new at-home STI testing and GLP-1 weight care, Wisp is building a category-defining digital telehealth platform for ...

This grant will support the continued clinical development of Debio 1453, a first-in-class antibiotic ... proof-of-concept obtained for the treatment of gonorrhea,” explained Morgane ...

The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...

By Amy Maxmen for KFF Health News. Broadcast version by Trimmel Gomes for Mississippi News Connection reporting for the KFF ...

Taking charge of your health is one of the most empowering things you can do, but the potential cost of medical care can ...

A vaccine targeting gonorrhea will soon be rolled out on the NHS. This will make England and Wales the first two countries in ...

Research has shown that the 4CMenB vaccine provides some protection against an infection from the Neisseria gonorrhoeae ...

England is set to become the first country in the world to roll out a national vaccination programme against gonorrhoea.

“There is a need for additional first-line treatment options to help patients with diffuse large B-cell lymphoma, since, unfortunately, approximately 40% still experience relapsed or refractory ...